The future of diagnostics
Built to provide rapid, reliable, and efficient sepsis detection in clinical settings. It combines laser spectroscopy with artificial intelligence to analyse the chemical signatures in blood samples that are uniquely associated with sepsis.
Delivers clinically actionable results in minutes, supporting real‑time decision making at the bedside. Instead of waiting 24–48 hours for conventional blood cultures to grow and be identified, clinicians can move from suspicion to targeted treatment much sooner and save lives.
AI‑powered precision analysis enhances diagnostic sensitivity and specificity, detecting subtle patterns that are often missed by traditional rule‑based or manual review alone. By improving overall accuracy and consistency, it delivers results that clinicians can trust every time.
With minimal sample volume for testing, it reduces burden on both patients and staff. This low‑volume requirement makes the technology easy to plug into existing hospital workflows and without major changes to current sampling routines.
Delivers results without the need for invasive procedures or lengthy lab processing, reducing burden on patients and clinical teams.
Pre-operative evaluation of patients (1 hour prior to surgery)
ICU patient admission screening & treatment
Post-operative monitoring (e.g. organ transplant, heart surgery, etc.)
Patient assessment before hospital discharge
Patient in ICU shows possible signs of sepsis
Blood sample is drawn for testing
Sample is spotted onto a diagnostic slide
Gyroram
Slide is inserted into the Gyroram device
The device automatically analyses the sample and displays the result